The report "Custom Antibody Market by Service (Development, Purification, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutic), Indication (Oncology, Immunology, Infectious, CVD), Competition, Region - Global Forecast to 2031", The global custom antibody market is projected to reach USD 1.13 billion by 2031, up from USD 0.72 billion in 2026, at a CAGR of 9.5% over the forecast period. The global custom antibody market is growing, driven by expansion of therapeutic antibody and biologics discovery pipelines.
Browse 470 market data Tables and 55 Figures spread through 370 Pages and in-depth TOC on "Custom Antibody Market by Service (Development, Purification, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutic), Indication (Oncology, Immunology, Infectious, CVD), Competition, Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/custom-antibody-market-164328301.html
The monoclonal antibodies segment accounted for the highest share by type in the custom antibody market in 2025.
The global custom antibody market by type is divided into mAbs, polyclonal antibodies, recombinant antibodies, and others. In 2025, mAbs held the largest share of the custom antibody market by type, driven by rising demand for highly specific, reproducible antibodies in pharmaceutical research, biomarker discovery, and diagnostic development. Monoclonal antibodies offer consistent target recognition and batch-to-batch reproducibility, making them suitable for applications requiring high specificity and reliable performance. Growing investment in biologics research, targeted therapeutics, and precision medicine, along with advances in hybridoma technology and antibody screening, further supports segment growth.
Oncology held the largest market share in 2025 and is expected to grow at the highest CAGR from 2026 to 2031.
Oncology is emerging as the fastest-growing segment in the custom antibody market, driven by increasing demand for highly specific antibodies for cancer research, biomarker identification, and targeted therapeutic development. Custom antibodies help identify and validate tumor-associated antigens, analyze cancer-related proteins, and investigate tumor biology and immune responses. The rising prevalence of cancer and growing investments in oncology research have increased demand for application-specific antibodies across pharmaceutical and biotechnology companies, academic and research institutes, and CROs. Advances in antibody engineering, recombinant antibody technologies, and immuno-oncology research are further expanding applications in cancer biomarker discovery, therapeutic target validation, and antibody-based drug development. These factors are expected to support continued growth in the oncology segment of the global custom antibody market.
North America accounted for the largest regional share in the custom antibody market in 2025.
Based on region, the custom antibody market is divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2025, North America held the largest share of the global custom antibody market, supported by a strong pharmaceutical and biotechnology industry, high levels of biomedical research funding, and extensive adoption of advanced antibody discovery and development technologies. The US remains the largest contributor to regional demand because of leading biopharmaceutical companies, CROs, academic research institutes, and specialized custom antibody service providers. Regional growth is further supported by increasing demand for highly specific antibodies in proteomics, biomarker discovery, precision medicine, diagnostics, and therapeutic development. In addition, growing outsourcing of antibody development by pharmaceutical, biotechnology, and academic organizations is strengthening demand for specialized service providers. The increasing adoption of recombinant and animal-free antibody technologies, high-throughput screening, single-cell sequencing, and AI-enabled antibody design is also supporting continued market growth across North America.
Key players in the custom antibody market include GenScript (US), Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Agilent Technologies, Inc. (US), and Merck KGaA (Germany).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com